Clinical Guidelines for Management of Chronic Non-Communicable Diseases (NCDs): An Integrated Provider's Manual for Hypertension & Cardio-Vascular Diseases, Diabetes, Asthma & COPD, and Epilepsy

Objectives

Provide an integrated Ministry of Health clinical manual for prevention, diagnosis, treatment and follow-up of major chronic non-communicable diseases, including hypertension, cardiovascular disease, diabetes, asthma, chronic obstructive pulmonary disease and epilepsy.[1]The available extracts chiefly set out clinical care pathways rather than a wider programme mission, strategic framework, population targets or accountability system.[2][3]

• Prevent cardiovascular disease and prolong life through effective detection and treatment of hypertension, risk-factor reduction and cardiovascular-risk stratification.[1][4]
• Identify hypertension through repeated blood-pressure measurement, classify severity, investigate possible co-morbidities and target-organ damage where resources allow, and use overall cardiovascular risk to determine treatment.[1][4]
• Reduce complications from hypertension, diabetes and ischaemic heart disease, including hypertensive crises, angina, acute coronary syndromes, stroke, heart failure and renal failure.[5][6][2][7][8]
• Promote modification of cardiovascular risks, including weight management, blood-pressure and diabetes control, smoking cessation, reduced harmful alcohol use, cholesterol management, healthy diet, moderate exercise and reduced salt intake.[6][7]
• Manage chronic kidney disease by controlling blood pressure, addressing renal and metabolic complications, avoiding nephrotoxic medicines, and referring for dialysis when clinically indicated.[8][9]
• Protect maternal and foetal wellbeing in hypertensive disorders of pregnancy through early recognition, stabilisation, seizure prevention or treatment, blood-pressure control, escalation of care and timely delivery planning.[9][10][11]

Implementation

Deliver integrated, risk-based clinical care through Ministry of Health services, using routine screening, standardised assessment, stepped treatment, clinical monitoring and referral between primary, secondary, tertiary and specialist facilities.[1][12]The extracts describe facility-based clinical actions and referral services, but do not specify wider governance arrangements, community-delivery mechanisms, programme financing, or formal reporting and performance-management systems.[2][13][7]

• Measure blood pressure for every adult at each health-facility visit, particularly people aged over 30 years and those with obesity, diabetes, relevant family history, smoking or alcohol risks, HIV, or pregnancy.[1]Ensure accurate readings through rest, correct arm support and cuff size, and repeat raised readings; diagnose hypertension from repeated measurements over at least two days, except for severely raised readings requiring same-day action.[1]
• Assess glucose, urine protein and blood, creatinine and HIV status where available, and use additional laboratory tests, electrocardiography and clinical examination to identify co-morbidities, secondary causes, organ damage and cardiovascular complications.[4][5]
• Apply lifestyle measures before and alongside medicines, use once-daily treatment where possible, and escalate antihypertensive medicines stepwise from a thiazide diuretic to a calcium-channel blocker, an angiotensin-converting enzyme inhibitor and, where required, a beta blocker.[12]Adapt treatment for pregnancy, myocardial infarction, heart failure, renal impairment and diabetic nephropathy, including medicine-specific contraindications and monitoring requirements.[14]
• Provide urgent assessment and inpatient high-dependency or intensive-care management for hypertensive emergencies, acute myocardial infarction, acute stroke, acute heart failure and acute renal failure when indicated.[5][2][13][7][8]Use investigations, intravenous and oral medicines, oxygen, electrocardiographic monitoring, supportive care and specialist referral according to the presenting condition and response to treatment.[5][2][7]
• Combine chronic ischaemic-heart-disease care with antiplatelet treatment, statins, stepwise anti-anginal medicines and specialist referral for persistent symptoms; admit and treat unstable angina or non-ST-segment elevation acute coronary syndrome with antiplatelet therapy, cardiac-marker testing, anticoagulation, pain control and referral for angiography where continuing chest pain warrants it.[6]
• Initiate acute stroke care with swallowing assessment, correction of dehydration and hyperglycaemia, treatment of fever and infection, prevention of pressure sores and deep-vein thrombosis, and early physiotherapy and speech therapy.[13]Continue rehabilitation, manage underlying conditions and provide secondary prevention with clinically appropriate antiplatelet, statin and antihypertensive therapy.[13]
• Monitor adherence at every visit, and monitor renal function and potassium when using angiotensin-converting enzyme inhibitors; check creatinine before treatment where possible and again two to four weeks after initiation.[12]Monitor heart failure, renal failure and chronic kidney disease through clinical status, blood pressure, renal function, electrolytes, urine findings and estimated glomerular filtration rate.[3][8][9]
• Differentiate pregnancy care across health-centre, hospital, labour-ward and central-hospital levels, with reassessment, admission, stabilisation, referral accompanied by health personnel and delivery planning based on severity, laboratory findings and gestational age.[9][10]Stabilise eclampsia with airway protection, oxygen, intravenous access and magnesium sulphate, monitor for toxicity and maternal and foetal deterioration, and plan delivery within 12 hours after treatment.[11]

Monitoring & Evaluation

Monitoring is principally clinical and embedded in patient assessment, treatment review, referral and follow-up, rather than a formal programme-wide monitoring and evaluation system. Across the supplied extracts, no performance indicators, routine reporting procedures, surveillance architecture, audit process, evaluation timetable or explicit accountability mechanism is specified.[1][12][5][2][3][9][11]

• Measure blood pressure at every adult health-facility visit and confirm hypertension through repeated measurements on separate days, except for very high readings that permit same-day diagnosis and treatment.[1]
• Classify blood-pressure severity and assess cardiovascular risk using diabetes, smoking, obesity, age, family history, dyslipidaemia, renal findings, target-organ damage and established cardiovascular disease.[4]
• Check medication adherence at every visit by asking about missed treatment days, and use risk category and blood-pressure response to determine whether treatment should be intensified.[12]
• Monitor creatinine before, where possible, and two to four weeks after starting an angiotensin-converting enzyme inhibitor; discontinue the medicine if creatinine rises by more than 30%.[12]Monitor renal function and potassium when using these medicines in renal failure.[14]
• Review hypertensive urgency one week after treatment begins and escalate management where necessary.[5]
• Assess acute coronary syndromes through symptoms, electrocardiographic changes, cardiac markers and, during unfractionated-heparin treatment, coagulation measures including activated partial thromboplastin time.[6]Review patients four weeks after discharge for persistent angina, possible cardiac failure and blood-pressure control.[6]
• Undertake continuous electrocardiographic monitoring during acute myocardial infarction and monitor vital signs, cardiac rhythm and response to diuretics, nitrates, ventilation or inotropic support in acute heart failure.[2][7]
• Monitor heart and kidney disease through measures including ejection fraction, blood pressure, renal function, electrolytes, potassium, electrocardiographic changes, urine findings and estimated glomerular filtration rate.[3][8]Calculate glomerular filtration rate during chronic kidney disease clinic visits and assess symptoms that may warrant dialysis referral.[9]
• Monitor hypertensive disorders in pregnancy through repeat blood-pressure measurement after rest, daily urine dipstick testing, four-hourly blood-pressure checks in pre-eclampsia, weight assessment, surveillance for eclampsia, foetal monitoring and laboratory testing.[9][10]Use clinical thresholds, including blood pressure, proteinuria, urine output, gestational age and laboratory abnormalities, to guide treatment escalation, referral and delivery decisions.[9][10]
• Monitor eclampsia closely through frequent blood-pressure checks, foetal-heart observation and assessment for magnesium sulphate toxicity using patellar reflexes, respiratory rate and urinary output.[11]Continue observation for at least 48 hours after delivery.[11]

Costing & Financing

No costs, budgets, financing sources, expenditure allocations, funding gaps, resource-mobilisation arrangements or economic assumptions are specified in the supplied extracts.[1][12][5][2][3][9][11]

• Require clinical resources including blood-pressure measurement, laboratory testing, electrocardiography, medicines and referral services, but provide no monetary values or financing arrangements for these inputs.[1][4][14]
• Identify hospital-level resource needs for severe cardiovascular presentations, including high-dependency or intensive-care admission, continuous monitoring, intravenous treatment and specialist referral, without costing them.[5][2][7]
• Refer to renal ultrasound, laboratory investigations, dialysis, rehabilitation, obstetric monitoring, admission and delivery services as clinically required, but do not state their costs, budget lines or sources of funding.[13][8][9][10]
• Specify medicines and monitoring inputs for eclampsia, including magnesium sulphate, calcium gluconate for toxicity, oxygen, intravenous access and foetal monitoring, without associated financial information.[11]